The Sudden Cardiac Arrest Foundation is dedicated to bringing you the latest news and developments in sudden cardiac arrest prevention and treatment.

New recommendations to bridge gaps in awareness, treatment of cardiac device infections

Report incorporates best practices from American Heart Association summit to improve cardiac implantable electronic device infection care DALLAS, TX -- Research finds as many as 1 in 20 patients with a cardiac implantable electronic device (CIED), such as a pacemaker or implantable defibrillator, develops an infection within three years of… Read More

PulsePoint to host contest promoting Sudden Cardiac Arrest Awareness Month

This October, during Sudden Cardiac Arrest Awareness Month, the non-profit PulsePoint Foundation is rewarding communities for identifying and registering AEDs. Each AED registered from October 1 through 31 will gain you an entry to win one of ten $500 Amazon gift cards. Collectively, the community that registers the most AEDs will be granted $5,… Read More

Medtronic addresses ICD recall

In June 2022, Medtronic began alerting physicians to the potential for reduced shock energy during therapy in its Cobalt™ and Crome™ portfolio of ICDs and CRT-Ds, along with comprehensive patient management recommendations. At the same time, Medtronic asked hospitals to quarantine and return a subset of non-implanted Cobalt and Crome devices for… Read More

Study reports novel findings in prediction of sudden death after myocardial infarction

BARCELONA, SPAIN -- Clinical data and cardiac magnetic resonance (CMR) imaging did not improve risk prediction for sudden cardiac death (SCD) after myocardial infarction in the largest pooled patient cohort collected to date. The late breaking research from the PROFID project was presented at ESC Congress 2022. SCD is responsible for… Read More

Cardiac arrest survival rate rising

The probability of surviving sudden cardiac arrest outside hospital in Sweden has more than doubled in 30 years. This is shown by a national Swedish register study covering more than 130,000 cases. Sudden cardiac arrest affects some 10,000 people in Sweden annually. Saving them is a race against the clock, and the actions of bystanders who can… Read More

Help for Latinas and Black women at higher risk of out-of-hospital cardiac arrest death

The American Heart Association's new campaign, Heroes Saving Hearts, inspire the Hispanic-Latino community to learn Hands-Only CPR. DALLAS, TX -- Despite improvement in CPR training, the survival rate for women experiencing cardiac arrest outside of a hospital has not improved significantly, especially for Hispanic women[1]. The American Heart… Read More

Genetic score detects those at risk for sudden cardiac death

Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients at highest risk for developing sudden cardiac death. To identify those at highest risk, researchers used a polygenic risk score that has been previously shown successful in predicting coronary artery disease. This Cedars-Sinai study, however, is… Read More

San Francisco launches use of PulsePoint mobile app to help save lives

SAN FRANCISCO, CA -- The San Francisco Department of Emergency Management and City officials today announced the launch of PulsePoint, a mobile phone application (PulsePoint app) designed to support public safety agencies increasing cardiac arrest survival rates through improved bystander performance and active resident support. San Francisco’s 9… Read More

Myocarditis risk significantly higher after COVID-19 infection vs. after a COVID-19 vaccine

Among almost 43 million people in England who received at least one COVID-19 vaccine dose, the risk of myocarditis was substantially higher in the four weeks after COVID-19 infection than after a first dose of a COVID-19 vaccine, according to new study in Circulation. Research Highlights: Among nearly 43 million people in England, ages 13 and… Read More

FDA announces recall of nearly 88,000 implantable cardiac devices due to risk of serious injury or death

The U.S. Food and Drug Administration (FDA) has announced that Medtronic is recalling 87,709 implantable cardiac devices due to the risk of a malfunction that could result in serious injury or death.  Devices included in the recall are Medtronic’s Cobalt XT, Cobalt and Crome implantable cardioverter defibrillators (ICDs) and cardiac… Read More